Ritonavir-induced carbamazepine toxicity [3]

Annals of Pharmacotherapy

Volumn 35, Issue 1, 2001, Pages 125-126

  Mateu De Antonio, J ^a   Grau, S ^a   Gimeno Bayon J L ^a   Carmona, A ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; INDINAVIR; LAMIVUDINE; PHENOBARBITAL; PHENYTOIN; RITONAVIR; SAQUINAVIR; STAVUDINE; TUBERCULOSTATIC AGENT; ZALCITABINE; ZIDOVUDINE;

ADULT; ALCOHOLISM; ATAXIA; CASE REPORT; DIPLOPIA; DROWSINESS; DRUG INDUCED DISEASE; EPILEPSY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; TUBERCULOSIS; VERTIGO;

EID: 0035105984     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10039     Document Type: Letter

References (6)

1. Protease inhibitors in patients with HIV diseases. Clinically important pharmacokinetic considerations
2. Significant interactions with new antiretrovirals and psychotropic drugs
3. Update: Clinically significant cytochrome P-450 drug interactions
4. A method for estimating the probability of adverse drug reactions
5. Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents